Ascentage Pharma’s Lisaftoclax (APG-2575) Gets FDA Green Light for Phase III Study
China-based Ascentage Pharma (HKG: 6855) has announced that it has received approval from the US...
August 2023
Jenscare Scientific and Lifetech Scientific Achieve Milestone with First Compassionate Use of LuX-Valve Plus
Partners Jenscare Scientific Co., Ltd. (HKG: 9877), a leading structural heart disease device manufacturer based...
GuangDong Pharmaceutical Association Releases Updated Off-Label Drug List for 2023
The GuangDong Pharmaceutical Association has released the 2023 version of its off-label drug list, marking...
Venus Medtech Receives FDA IDE Approval for VenusP-Valve, a Milestone for Chinese Heart Valve Technology
Venus Medtech (Hangzhou) Inc. (HKG: 2500) has announced obtaining Investigational Device Exemption (IDE) approval from...
MicroPort CardioFlow Announces Positive Results for Transcatheter Mitral Valve Replacement System
China-based MicroPort Scientific Corp’s spin-off, MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), has announced positive...
Hansoh Pharmaceutical Regains Rights to Ameile After EQRx Partnership Cancellation
Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced the cancellation of its partnership and...
Jumpcan Pharmaceutical Partners with Nanjing Zenshine for Exclusive Promotion Rights of ZX-7101A in China
China-based Jumpcan Pharmaceutical (SHA: 600566) has announced a strategic partnership with fellow Chinese firm Nanjing...
Gilead Sciences Inc. Reports 5% YOY Revenue Increase in Q2 2023 Financials
US-based pharmaceutical major Gilead Sciences Inc., (NASDAQ: GILD) has released its financial results for the...
Amgen Inc. Reports 7% YOY Revenue Increase in Q2 2023 Financials
US-based biotechnology company Amgen Inc., (NASDAQ: AMGN) has released its financial results for the second...
GSK Files Patent Infringement Lawsuit Against Pfizer’s RSV Vaccine Abrysvo
UK pharmaceutical giant GlaxoSmithKline (NYSE: GSK) has taken US-based Pfizer Inc., (NYSE: PFE) to court,...
Novartis AG and Ionis Pharmaceuticals Renew Collaboration on Lp(a)-Driven CVD Drug
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has returned to US-based Ionis Pharmaceuticals Inc., (NASDAQ:...
Grand Pharmaceutical Group Gets NMPA Approval for Generic Eplerenone for Hypertension
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced that it has received marketing approval...
Chia Tai Tianqing Secures Exclusive Rights to InventisBio’s D-1553 in China Licensing Deal
China-based Chia Tai Tianqing has signed a licensing agreement with compatriot firm InventisBio, securing exclusive...
DaVinci Single Port System Launches in Hainan with Successful Surgeries
The DaVinci Single Port robot-assisted surgical system technology has been successfully implemented in Boao, Hainan...
Shanghai’s SMPA Reduces Ceiling Price for Non-Winning Bids in Artificial Joint VBP Tender
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has issued a notification regarding an artificial joint volume-based...
Kunshan Yiyuan Medical Technology Secures Over RMB 100 Million in Series B Financing
Kunshan Yiyuan Medical Technology Co., Ltd (Medical Source), a company in China that specializes in...
HuidaGene Strikes Licensing Deal with Kactus Biosystems for Gene Editing Enzyme hfCas12Max
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced a licensing agreement with fellow Shanghai-based firm...
Novartis China’s Business Growth Lead Zhu Jiakang Departs for Personal Reasons
Swiss pharmaceutical giant Novartis (NYSE: NVS) has seen the departure of Zhu Jiakang, who led...
BeiGene’s Q2 2023 Financial Report Highlights 81.8% YOY Product Revenue Growth
China-based biotech company BeiGene (SHA: 688235, HKG: 6160, NASDAQ: BGNE) has released its financial report...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...